Nova Leap Health Corp.
NVLPF
$0.1856
-$0.0044-2.32%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.52% | -2.25% | -5.08% | 0.53% | -3.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.52% | -2.25% | -5.08% | 0.53% | -3.37% |
| Cost of Revenue | 1.72% | -3.23% | -7.47% | -3.80% | -9.69% |
| Gross Profit | -1.30% | -0.60% | -0.97% | 8.48% | 8.08% |
| SG&A Expenses | 4.95% | 2.17% | -1.77% | -4.31% | -13.44% |
| Depreciation & Amortization | -21.77% | -28.54% | -45.91% | -35.77% | -38.35% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.09% | -2.31% | -7.16% | -5.11% | -12.22% |
| Operating Income | -30.42% | -0.19% | 112.25% | 202.08% | 198.91% |
| Income Before Tax | 189.29% | -129.93% | 215.02% | 250.34% | 3.31% |
| Income Tax Expenses | 176.06% | -47.55% | 197.97% | 214.89% | 9.15% |
| Earnings from Continuing Operations | 192.84% | -154.65% | 223.71% | 259.35% | 1.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 192.84% | -154.65% | 223.71% | 259.35% | 1.62% |
| EBIT | -30.42% | -0.19% | 112.25% | 202.08% | 198.91% |
| EBITDA | -35.61% | -14.23% | 3.51% | 558.20% | 718.49% |
| EPS Basic | 192.79% | -154.55% | 223.81% | 258.82% | 0.89% |
| Normalized Basic EPS | 2,200.00% | -105.71% | 242.11% | 300.00% | 92.59% |
| EPS Diluted | 190.09% | -160.00% | 223.81% | 258.82% | 4.31% |
| Normalized Diluted EPS | 2,200.00% | -105.71% | 242.11% | 300.00% | 92.59% |
| Average Basic Shares Outstanding | 0.17% | 0.00% | 1.53% | 1.31% | -0.06% |
| Average Diluted Shares Outstanding | 0.17% | 0.31% | 1.53% | 1.31% | -0.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |